BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1186921)

  • 1. Effect of nafenopin (SU-13,437) on liver function: mechanism of choleretic effect.
    Levine WG; Braunstein HR; Mejier DK
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):221-34. PubMed ID: 1186921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nafenopin (SU-13,437) on liver functions. Hepatic uptake and biliary excretion of ouabain in the rat.
    Meijer DK; Bognacki J; Levine WG
    Drug Metab Dispos; 1975; 3(3):220-5. PubMed ID: 238821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nafenopin (SU-13,437) on liver function: influence on the hepatic transport of organic anions.
    Meijer DK; Bognacki J; Levine WG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):235-50. PubMed ID: 810733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nafenopin (SU-13437) on liver function. Influence on the hepatic transport of phenolphthalein glucuronide and chlorothiazide.
    Uesugi T; Levine WG
    Drug Metab Dispos; 1976; 4(2):107-11. PubMed ID: 5253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some biochemical changes associated with nafenopin-induced liver growth in the rat.
    Levine WG; Ord MG; Stocken LA
    Biochem Pharmacol; 1977 May; 26(10):939-42. PubMed ID: 861041
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary excretion of 3,4-benzpyrene in nafenopin-treated rats.
    Levine WG; Bognacki J
    J Pharmacol Exp Ther; 1976 Feb; 196(2):486-92. PubMed ID: 1255492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane.
    Jedlitschky G; Leier I; Böhme M; Buchholz U; Bar-Tana J; Keppler D
    Biochem Pharmacol; 1994 Sep; 48(6):1113-20. PubMed ID: 7945404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choleretic effect of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choleretic effect of iodipamide.
    Feld GK; Loeb PM; Berk RN; Wheeler HO
    J Clin Invest; 1975 Mar; 55(3):528-35. PubMed ID: 1117066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the hypolipidemic drug nafenopin (2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy)propionic acid; TPIA; SU-13,437), on the hepatic disposition of foreign compounds in the rat.
    Levine WG
    Drug Metab Dispos; 1974; 2(2):178-86. PubMed ID: 4150998
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible mechanism of choleretic action of 3-(2,4,5-triethoxybenzoyl)-propionic acid (AA-149) in dogs.
    Satoh H; Kanno M; Maki Y
    Eur J Pharmacol; 1978 Mar; 48(1):125-32. PubMed ID: 639840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile-salt-dependent and independent choleresis induced by bucolome in the rat.
    Kitani K; Morita Y; Miura R; Kanai S
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1155-61. PubMed ID: 21733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on increased bile formation produced by polyoxybenzenes in rats.
    Tanayama S; Kanai Y
    Jpn J Pharmacol; 1977 Feb; 27(1):71-8. PubMed ID: 864884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choleretic mechanisms of sodium taurocholate, secretin, and glucagon.
    Russell TR; Searle GL; Jones RS
    Surgery; 1975 Apr; 77(4):498-504. PubMed ID: 1145427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein.
    Meijer DK; Vonk RJ; Keulemans K; Weitering JG
    J Pharmacol Exp Ther; 1977 Jul; 202(1):8-21. PubMed ID: 874820
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of butylated hydroxytoluene (BHT) on biliary excretion of xenobiotics and bile flow in rats.
    Choe SY; Kim HM; Yang KH
    Drug Chem Toxicol; 1984; 7(2):149-65. PubMed ID: 6434281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism and morphologic changes in the liver of nafenopin-treated rats.
    Tuchweber B; Kourounakis P; Latour JG
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):309-21. PubMed ID: 984981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver.
    Gärtner U; Stockert RJ; Levine WG; Wolkoff AW
    Gastroenterology; 1982 Dec; 83(6):1163-9. PubMed ID: 6751925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of pyrimidine and nucleic acid synthesis during adaptive growth of liver induced by nafenopin, a peroxisome proliferator. An in vivo study.
    Seifert J; Mostecká H
    Carcinogenesis; 1989 Aug; 10(8):1383-8. PubMed ID: 2473851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey.
    Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N
    Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.